Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
Patent 4870023 Issued on September 26, 1989. Estimated Expiration Date: February 8, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
435/235.1, VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING435/243, MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR435/320.1, VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.)435/69.3, Antigens435/69.7, Fusion proteins or polypeptides530/350, PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES530/820, PROTEINS FROM MICRO-ORGANISMS530/826, Viruses536/23.1, DNA or RNA fragments or modified forms thereof (e.g., genes, etc.)536/23.4, Encodes a fusion protein930/10, PEPTIDE OR PROTEIN SEQUENCE930/220Viral peptide or viral protein (See note 6)
The present invention is directed to recombinant baculoviruses which encode fusion polyhedrin proteins capable of forming occlusion bodies containing foreign peptides. The recombinant baculoviruses of the invention are formed by insertion into or replacement of regions of the polyhedrin gene that are not essential for occlusion body formation, with foreign DNA fragments by recombinant DNA techniques. The recombinant occlusion bodies produced in accordance with the present invention have uses in vaccine formulations, immunoassays, immobilized enzyme reactions, as biological insecticides, and as expression vectors.
Other References
Carstens et al. (1987) J. Gen. Vir., 68: 901-5
Smith et al. (1981), J. Virology, 39: 125-37
Kuroda et al. (1986), EMBO J., 5: 1359-65
Harrap, 1972, Virology, 50: 124-132
Engstrom, 1974, Biochem. Exp. Biol., 11: 7
Epstein et al., 1977, Biochem. J., 167: 321-332
Rohrmann et al., 1977, Biochemistry, 16: 1634
Maruniak et al., 1978, J. Invert. Pathol., 32: 196-201
Tinsley, T. and Harrap, K., 1978, "Comprehensive Virology", vol. 12, pp. 1-101, H. Fraenkel-Conrat and R. Wagner, Eds., Plenum Press, NY
Scharnhorst, D. and Weaver, R., 1980, Virology, 102: 468-472
McIntosh et al., 1981, J. Invert. Pathol., 37: 258-264
Tweeten et al., 1981, Microbiological Rev., 45: 379-408
Duncan et al., 1983, J. Gen. Virology, 64: 1531-1542
Tjia et al., 1979, Virology, 99: 399-409
Rohrmann et al., 1981, J. Mol. Evol., 17: 329-333
Vlak et al., 1981, J. Virology, 40: 1531-1542
Adang et al., 1982, J. Virology, 44: 782-793
Smith, G. and Summers, M., 1982, Virology, 123: 393-406
Vlak et al., 1982, Virology, 123: 222-228
Erlandson et al., 1983, Virology, 126: 398-402
Smith et al., 1983, J. Virology, 45: 215-225
Smith et al., 1983, J. Virology, 46: 584-593
Knell & Summers, 1984, J. Gen. Virology, 65: 445-450
Heng et al., 1985, Scientia Sinica, pp. 1051-1059
Leisy et al., 1986, Virology, 153: 280-288
Miller, L. K., 1981, Genetic Engineering in Plant Sciences, Praeger Publishers, New York, pp. 203-224
Smith et al., 1983, Mol. Cell. Biol., 3: 2156-2165
Maeda et al., 1984, Proc. Japan Acad., 60: 423-426
Pennock et al., 1984, Mol. Cell. Biol., 4: 399-406
Carbonell et al., 1985, J. Virology, 56: 153-160
Maeda et al., 1985, Nature, 315: 592-594
Miyamoto et al., 1985, Mol. Cell. Biol., 5: 2860-2865
Summers, M. D. and Smith, G., 1985, Genetic Engineering of Baculoviruses, Genetically Altered Viruses and the Environment; Meeting, Cold Spring Harbor, N.Y., Apr. 28-May 1, 1985, pp. 319-331
Matsura et al., 1986, J. Gen. Virol., 67: 1515-1529
Possee, 1986, Virus Research, 5: 43-59
Estes et al., 1987, J. Virology, 61: 1488-1494
Hu et al., 1987, J. Virology, 61: 3617-3620
Inumaru et al., 1987, J. Gen. Virol., 68: 1627-1635
Jeang et al., 1987, J. Virology, 61: 1761-1764
Matsuura et al., 1987, J. Gen. Virology, 68: 1233-1250
Rice et al., 1987, J. Virology, 61: 1712-1716
Luckow et al., 1988, Biotechnology, 6: 47-55
Hohmann et al., 1983, Virology, 125: 432-444
Quant et al., 1984, Applied and Environmental Microbiology, 48: 732`736
Huang et al., 1985, Virology, 143: 380-391
Steeves et al., 1974, J. Virology, 14: 187-189
Dalyrample et al., 1981, in "The Replication of Negative Strand Viruses", ed. Bishop, D. and Compans., R., Elseveir North Holland Publishers, N.Y., pp. 167-172
Massey et al., 1981, Virology, 115: 20-32
Gonzalez-Scarano et al., 1982, Virology, 120: 42-53
Mathews et al., 1982, J. Immunol., 129: 2763-2767
Matsuno et al., 1983, Infection and Immunity, 39: 155-158
Warren, 1985, "Vaccines", 85, Lerner, R. et al., Eds., Cold Spring Harbor Laboratory, New York, pp. 373-376
Granoff et al., 1986, J. Infect. Dis., 153: 448-461
European Patent Application #0 127 839, Smith et al., Application No. 84105841.5, published Dec. 12, 1984